AdvaMedDx VALID Act Webinar
The VALID Act marks a milestone in AdvaMedDx efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.
VALID Act
Diagnostics Regulatory Reform
AdvaMedDx supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all…
AdvaMed Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
AdvaMed Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement:
AdvaMedDx VALID Assessment Framework
AdvaMedDx developed the VALID Assessment Framework as a tool to analyze the legislation.
VALID Act 2020 Comprehensive Summary
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
AdvaMedDx VALID Act Webinar, March 20, 2020 – Presentation
On March 5, 2020, the VALID Act was introduced in the Senate and House.
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers…